India’s drugs regulator gives nod to phase-3 clinical trial of Covid vaccine Covovax, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The Subject Expert Committee (SEC) on Covid-19 of CDSCO had, on March 5, recommended permission for conducting the phase-3 clinical trial for Covovax as a booster dose in adults who have been fully vaccinated with either Covaxin or Covishield at least three months ago., The Subject Expert Committee (SEC) on Covid-19 of CDSCO had, on March 5, recommended permission for conducting the phase-3 clinical trial for Covovax as a booster dose in adults who have been fully vaccinated with either Covaxin or Covishield at least three months ago., , Read More